IFNA1 and COVID-19: Our previous studies showed that serum IFN-α levels were higher in patients who developed pneumonia and hypoxemic respiratory failure, and were strongly predictive of hypoxemic respiratory failure in the early phase of COVID-19 due to Delta or precedent variants before Omicron emerged (22, 23).